Contact

Nagasri Shankar, MD

Position: GI Fellow - PGY6

Personal Statement:

What are your clinical interests? 

  • Management of patients with cirrhosis and liver transplantation.

What are your hobbies and favorite activities outside of medicine?

  • Singing Disney songs to my 5-month-old daughter, eating pizza and watching Netflix with my husband, listening to epic fantasies on audible.

What is the best thing about San Antonio? 

  • The people.

Why would you recommend the UTHSA GI fellowship?

  • I recommend this fellowship to anyone who wants to feel confident on their own after fellowship. The large volume of procedures, varied pathology, and staff dedication to teaching make this the best program for gastroenterology fellowship.

Hometown

  • Plano, TX

Education

Residency: Baylor University Medical Center- Dallas
Medical School: Texas Tech University Paul L Foster SOM

Research

  • Performance of serum cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates
  • Role of Novel Kidney Biomarkers in Patients with Cirrhosis and After Liver Transplantation
  • Extrahepatic Causes of Death in Cirrhosis Compared to Other Chronic Conditions in the US, 1999-2017

Awards & Accomplishments

  • “Best of The Liver Meeting 2019” recognition: “Cystatin C Predicts Need For Hemodialysis, SLK, And Transplant-Free Survival In Liver Transplant Candidates”.
  • Mark Armstrong Award: 1st place winner of Resident Clinical Oral Vignette Competition, Texas Chapter of American College of Physicians, October 2019.

Publications

  • Extrahepatic Causes of Death in Cirrhosis compared to Other Chronic Diseases • Aim: to better understand the national impact of cirrhosis-related mortality in the US as compared to other major chronic diseases • Status: poster presentations completed, manuscript accepted for publication • Roles: study design, data collection, and poster/abstract preparation and manuscript preparation.
  • Cystatin C as a Renal Biomarker in Liver Transplant Candidates • Aim: to understand the role of serum Cystatin C as an alternative to creatinine in estimating renal function in end stage liver disease patients as well as its role in predicting clinical outcomes. • Status: poster and oral presentations complete (Transplant Plenary session at Liver Meeting, November 2019). Manuscript and review article in preparation • Roles: data analysis, poster/abstract and manuscript preparation, oral presentation Shankar N, Ramani A, Griffin C, Agbim U, Kim D, Ahmed A, Asrani SK. Extrahepatic causes of death in cirrhosis compared to other chronic conditions 1999-2017.
  • In press. Shankar, N. Linzay, C. Rowe, K.. (2020, June 01). Vasoactive intestinal peptide-oma causing refractory diarrhea in a young woman. https://doi.org/10.1080/08998280.2020.1778963 Sarosiek I., Bashashati M., Alvarez A., Hall M., Shankar N, Gomez Y, McCallum R.W, Sarosiek J. Lubiprostone accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With chronic Constipation. American Journal of the Medical Sciences. 2016 Sept; 352(3), 231–238. 10.1016/j.amjms.2016.05.012.